Enerpac Tool Group adds ex A.O. Smith CFO Charles Lauber to board
Bitget2026/10/08 20:45Enerpac Tool Group expanded its board to nine directors, electing Charles T. Lauber effective today. Lauber previously served as executive vice president and CFO of A. O. Smith from 2019 to 2026. He spent 15 years at Ernst & Young, rising to senior manager advising on accounting, audit, tax, financial reporting. Lauber is a director at H.B. Fuller, serving on its audit committee, personnel and compensation committee. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enerpac Tool Group Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081645PRIMZONEFULLFEED9842503) on October 08, 2026, and is solely responsible for the information contained therein.
- Enerpac Tool Group expanded its board to nine directors, electing Charles T. Lauber effective today.
- Lauber previously served as executive vice president and CFO of A. O. Smith from 2019 to 2026.
- He spent 15 years at Ernst & Young, rising to senior manager advising on accounting, audit, tax, financial reporting.
- Lauber is a director at H.B. Fuller, serving on its audit committee, personnel and compensation committee.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
BUZZ-3M India shares fall to 19-month low due to quarterly profit decline
Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.
After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.
Hong Kong live music service provider Guitar Group applies for US IPO, aiming to raise $31 million
Guitar Group, a provider of music performance events, guitar-making workshops, and guitar repair services, submitted an application to the U.S. Securities and Exchange Commission (SEC) on Thursday, seeking to raise up to $31 million through an initial public offering (IPO).
Crypto prices
More
